Operating Margin in % of Sunshine Biopharma Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Sunshine Biopharma Inc. quarterly/annual Operating Margin history and growth rate from Q1 2019 to Q3 2025.
  • Sunshine Biopharma Inc. Operating Margin for the quarter ending September 30, 2025 was -17.5 %, a 17.9% decline year-over-year.
  • Sunshine Biopharma Inc. annual Operating Margin for 2024 was -16.7 %, a 16.1% increase from 2023.
  • Sunshine Biopharma Inc. annual Operating Margin for 2023 was -19.9 %, a 96.8% increase from 2022.
  • Sunshine Biopharma Inc. annual Operating Margin for 2022 was -621 %, a 41.8% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)

Sunshine Biopharma Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -17.5 -2.65 -17.9% Jul 1, 2025 Sep 30, 2025
Q2 2025 -18 -3.04 -20.3% Apr 1, 2025 Jun 30, 2025
Q1 2025 -15.9 +0.22 +1.37% Jan 1, 2025 Mar 31, 2025
Q4 2024 -16.7 +3.2 +16.1% Oct 1, 2024 Dec 31, 2024
Q3 2024 -14.8 +118 +88.8% Jul 1, 2024 Sep 30, 2024
Q2 2024 -15 +177 +92.2% Apr 1, 2024 Jun 30, 2024
Q1 2024 -16.1 +287 +94.7% Jan 1, 2024 Mar 31, 2024
Q4 2023 -19.9 +601 +96.8% Oct 1, 2023 Dec 31, 2023
Q3 2023 -133 +665 +83.4% Jul 1, 2023 Sep 30, 2023
Q2 2023 -192 +468 +70.9% Apr 1, 2023 Jun 30, 2023
Q1 2023 -303 +465 +60.6% Jan 1, 2023 Mar 31, 2023
Q4 2022 -621 +447 +41.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 -798 +664 +45.4% Jul 1, 2022 Sep 30, 2022
Q2 2022 -660 +843 +56.1% Apr 1, 2022 Jun 30, 2022
Q1 2022 -768 +1.04K +57.5% Jan 1, 2022 Mar 31, 2022
Q4 2021 -1.07K -260 -32.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -1.46K -564 -62.9% Jul 1, 2021 Sep 30, 2021
Q2 2021 -1.5K -98.7 -7.03% Apr 1, 2021 Jun 30, 2021
Q1 2021 -1.81K -68.1 -3.91% Jan 1, 2021 Mar 31, 2021
Q4 2020 -808 +2.23K +73.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -897 -1.54K -239% Jul 1, 2020 Sep 30, 2020
Q2 2020 -1.4K -2.09K -304% Apr 1, 2020 Jun 30, 2020
Q1 2020 -1.74K -2.97K -241% Jan 1, 2020 Mar 31, 2020
Q4 2019 -3.04K Oct 1, 2019 Dec 31, 2019
Q3 2019 644 Jul 1, 2019 Sep 30, 2019
Q2 2019 689 Apr 1, 2019 Jun 30, 2019
Q1 2019 1.23K Jan 1, 2019 Mar 31, 2019

Sunshine Biopharma Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -16.7 +3.2 +16.1% Jan 1, 2024 Dec 31, 2024
2023 -19.9 +601 +96.8% Jan 1, 2023 Dec 31, 2023
2022 -621 +447 +41.8% Jan 1, 2022 Dec 31, 2022
2021 -1.07K -260 -32.2% Jan 1, 2021 Dec 31, 2021
2020 -808 +2.23K +73.4% Jan 1, 2020 Dec 31, 2020
2019 -3.04K Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.